Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2018

In 2018, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 11.35% of shares outstanding on 12 Jan 2018 to 9.12% on 31 Dec 2018, a change of -2.23 percentage points. The year's high was 11.35% on 12 Jan 2018 and its low 5.66% on 15 Jun 2018, averaging 8.71% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.23 days on 31 Aug 2018. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2018

2018 in figures

Start of year
11.35% (12 Jan 2018)
End of year
9.12% (31 Dec 2018)
Change
-2.23 pp
High
11.35% (12 Jan 2018)
Low
5.66% (15 Jun 2018)
Average
8.71%
Highest days to cover
10.23 (31 Aug 2018)
SEC filings marked
8

Every report in 2018

COLLEGIUM PHARMACEUTICAL, INC short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201811.35%8.29
31 Jan 201810.13%4.01
15 Feb 201810.03%5.02
28 Feb 20189.10%6.44
15 Mar 20188.13%3.6410-K filed, results (8-K)
29 Mar 20187.31%5.61
13 Apr 20188.02%4.79
30 Apr 20186.00%5.80
15 May 20185.82%3.9510-Q filed, results (8-K)
31 May 20186.75%6.40
15 Jun 20185.66%3.84
29 Jun 20186.88%3.83
13 Jul 20188.17%2.82
31 Jul 20188.76%6.34
15 Aug 20189.47%5.2910-Q filed, results (8-K)
31 Aug 201810.65%10.23
14 Sep 201810.67%9.02
28 Sep 201811.30%8.56
15 Oct 20189.40%6.52
31 Oct 201810.64%10.21
15 Nov 201810.04%6.1810-Q filed, results (8-K)
30 Nov 20187.80%5.73
14 Dec 20187.86%5.88
31 Dec 20189.12%7.68

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.